CRBU
Caribou Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Caribou Biosciences, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Fund move
Fund move
Caribou Biosciences, Inc.
0.43
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $13.8M | 16.12% | +264.70% | |
| 2 | PfizerPfizer | $7.9M | 9.23% | 0.00% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $7.4M | 8.68% | +11.72% | |
| 4 | Mackenzie FinancialMackenzie Financial | $6.4M | 7.53% | +287.23% | |
| 5 | Renaissance TechnologiesRenaissance Technologies | $4.9M | 5.72% | +7.07% | |
| 6 | Kynam Capital ManagementKynam | $4.4M | 5.16% | 0.00% | |
| 7 | Geode Capital ManagementGeodeindex-like | $4.2M | 4.90% | +133.30% | |
| 8 | Acadian Asset ManagementAcadian | $3.1M | 3.66% | +91.83% | |
| 9 | State StreetState Streetindex-like | $2.9M | 3.37% | +285.79% | |
| 10 | Bank of AmericaBank of America | $2.5M | 2.91% | +8.77% | |
| 11 | Two Sigma InvestmentsTwo Sigma | $1.8M | 2.16% | −40.55% | |
| 12 | Dimensional Fund AdvisorsDimensional | $1.7M | 2.01% | +44.88% | |
| 13 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.4M | 1.60% | +38.63% | |
| 14 | FMRFMR | $1.3M | 1.50% | +0.44% | |
| 15 | Northern TrustNorthern Trustindex-like | $1.3M | 1.47% | +227.45% | |
| 16 | Maverick CapitalMaverick Capital | $1.1M | 1.35% | 0.00% | |
| 17 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.1M | 1.27% | new | |
| 18 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.1M | 1.25% | +16.59% | |
| 19 | Qube Research & TechnologiesQube Research & Technologies | $960,529 | 1.13% | +208.86% | |
| 20 | UBS GroupUBS | $910,573 | 1.07% | +99.63% | |
| 21 | 72 Investment Holdings72 Investment | $834,358 | 0.98% | 0.00% | |
| 22 | GSA Capital PartnersGSA Capital Partners | $816,000 | 0.96% | −3.60% | |
| 23 | Jacobs Levy Equity ManagementJacobs Levy Equity | $723,323 | 0.85% | +14.50% | |
| 24 | Cambridge Investment Research AdvisorsCambridge Investment Research | $673,000 | 0.79% | −30.09% | |
| 25 | Marshall WaceMarshall Wace | $661,205 | 0.77% | −68.84% |
137 managers report $85.3M of Caribou Biosciences on form 13F for the quarter ended Jun 30 '26. 19 of them hold 80% of it; BlackRock is largest at 16.12%.
Linked news
NewsNo implied move.
No implied move.
Expected move
No implied move.